IRCT201011025073N1CompletedPhase 4
Comparison between the efficacy of Plavix and Clopidex in Post stroke patients with Ischemic heart disease
Baqiyatallah University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 85 years (—)
- Sex
- All
Inclusion Criteria
- •[Inclusion criteria]: Patients with Ischemic Heart Disease or ischemia; Patients consent for taking part in study; Patient cooperation in experiment pursuit and taking drugs; Patients shouldn’t be participating in any other clinical trial; Not having any drug taking record in the last month,
- •[Exclusion criteria]: Existence of any hemorrhagic diseases, for instance peptic ulcer and inner-cranial hemorrhage; Existence of accompanied diseases interfering with drugs taken; Any record of allergy to Palvix or Clopidex; Any contraindications for taking Palvix or Clopidex. (Thrombocytopenia, liver disorders, Neutropenia-…); Those of patients who needed some mechanical hemodynamic support like using balloon pump; age more than 85 years and under 18 years.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Eraddication of Helicobacter pylori for quadruple therapy with base of Clarithromycin compared with LevofloxaciHelicobacter pylori infection.Helicobacter pylorB96.81IRCT20171223038001N1Esfahan University of Medical Sciences210
Recruiting
Phase 3
evofloxacin in Hematopoetic stem cell transplantIRCT20100127003210N17Shahid Beheshti University of Medical Sciences60
Completed
Phase 3
Efficacy of Levofloxacin- containing versus Clarithromycin -containing Sequential Therapies in Helicobacter pylori Eradicatiogastric ulcer or erosion-deudenal ulcer or erosion.Gastric ulcer-Duodenal ulcer- Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersk25-K26 -BIRCT2015030820178N2Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center182
Active, not recruiting
Phase 1
Comparative use of two local anesthetics in locoregional anesthesia in ambulatory surgeryEUCTR2019-003972-37-ESHospital Arnau de Vilanova - Lliria100
Completed
Phase 2
Valerian for prevention of neuropsychiatric adverse effects of Efavirenz in HIV positive patientseuropsychiatric disorders.A cluster of psychotic phenomena that occur during or following drug useF10-19.5IRCT201504053449N18Vice Chancellor for Research, Tehran University of Medical Sciences50